Financhill
Sell
33

APYX Quote, Financials, Valuation and Earnings

Last price:
$1.58
Seasonality move :
5.24%
Day range:
$1.54 - $1.61
52-week range:
$0.97 - $2.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.12x
P/B ratio:
5.35x
Volume:
88.6K
Avg. volume:
78.2K
1-year change:
-37.2%
Market cap:
$59.1M
Revenue:
$52.3M
EPS (TTM):
-$0.83

Earnings Data

Next earnings date for APYX
Mar 21
2025
Most recent earnings per share
-$0.14
Beat by $0.05
(Nov 8/2024)
Consensus Estimate
-$0.19
(Nov 8/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

APYX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/21/2025 Q4 $13M -- -- -$0.16 --
11/08/2024 Q3 $11.4M $11.5M -$0.14 -$0.19 $0.05
08/08/2024 Q2 $11.7M $12.1M -$0.19 -$0.19 $0.00
05/09/2024 Q1 $9.5M $10.2M -$0.22 -$0.19 -$0.03
03/21/2024 Q4 $14.3M $14.7M -$0.28 -$0.22 -$0.07
11/09/2023 Q3 -- -- -$0.13 -$0.11 -$0.02
08/10/2023 Q2 -- -- -$0.03 -$0.09 $0.06
05/11/2023 Q1 -- -- -$0.10 -$0.14 $0.04
03/16/2023 Q4 -- -- -$0.17 -$0.14 -$0.03
11/10/2022 Q3 -- -- -$0.17 -$0.14 -$0.03
08/11/2022 Q2 -- -- -$0.16 -$0.19 $0.03
05/12/2022 Q1 -- -- -$0.17 -$0.15 -$0.02
03/17/2022 Q4 -- -- -$0.06 -$0.11 $0.05
11/11/2021 Q3 -- -- -$0.12 -$0.15 $0.03
08/12/2021 Q2 -- -- -$0.12 -$0.15 $0.03
05/12/2021 Q1 -- -- -$0.14 -$0.15 $0.00
03/31/2021 Q4 -- -- -$0.04 -$0.10 $0.06
11/09/2020 Q3 -- -- -$0.11 -$0.17 $0.06
08/10/2020 Q2 -- -- -$0.14 -$0.21 $0.07
05/11/2020 Q1 -- -- -$0.06 -$0.25 $0.19
03/16/2020 Q4 -- -- -$0.16 -$0.19 $0.03
11/11/2019 Q3 -- -- -$0.13 -$0.18 $0.05
08/07/2019 Q2 -- -- -- -$0.18 --
05/08/2019 Q1 -- -- -- -$0.18 --
03/13/2019 Q4 -- -- -- -$0.10 --
11/01/2018 Q3 -- -- -- -$0.11 --
08/01/2018 Q2 -- -- -- -- --
05/14/2018 Q1 -- -- -- -- --
03/12/2018 Q4 -- -- -- -- --
11/02/2017 Q3 -- -- -- -- --
08/02/2017 Q2 -- -- -- -- --
05/15/2017 Q1 -- -- -- -- --
03/09/2017 Q4 -- -- -- -- --
10/26/2016 Q3 -- -- -- -- --
08/01/2016 Q2 -- -- -- -- --
05/11/2016 Q1 -- -- -- -- --
01/06/2016 Q4 -- -- -- -- --
11/05/2015 Q3 -- -- -- -- --
08/06/2015 Q2 -- -- -- -- --
05/08/2015 Q1 -- -- -- -- --
02/27/2015 Q4 -- -- -- -- --

Apyx Medical Earnings Questions

  • How Much did Apyx Medical Generate in Revenue Last Quarter?

    Apyx Medical reported $11.5M worth of top line sales in its most recent quarter.

  • Did Apyx Medical Beat Earnings Last Quarter?

    Apyx Medical announced earnings per share of -$0.14 which represents a beat of analyst forecast a -$0.19 per share.

  • Is Apyx Medical Profitable?

    Apyx Medical reported $7M that represents $0.20 per share over the last quarter.

  • What is the Analyst Consensus for Apyx Medical EPS Next Year?

    Apyx Medical's earnings are forecast to decrease from -$0.54 per share to -$0.47 per share next year representing a decrease of -31.02%.

  • When is Apyx Medical's Earnings Date?

    Apyx Medical's next earnings date is March 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock